Eli Lilly And Co Stock Price, News & Analysis (NYSE:LLY)

Eli Lilly And Co trades on the New York Stock Exchange (NYSE) under the ticker symbol "LLY."

Eli Lilly And Co announced a quarterly dividend on Monday, October 21st. Shareholders of record on Friday, November 15th will be paid a dividend of $0.645 per share on Tuesday, December 10th. This represents a $2.58 dividend on an annualized basis and a yield of 2.35%. View Eli Lilly And Co's Dividend History.

Eli Lilly And Co (NYSE:LLY) posted its earnings results on Tuesday, July, 30th. The company reported $1.50 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $1.45 by $0.05. The firm had revenue of $5.64 billion for the quarter, compared to analysts' expectations of $5.59 billion. Eli Lilly And Co had a net margin of 33.76% and a return on equity of 70.86%. The company's quarterly revenue was up .9% compared to the same quarter last year. During the same period in the prior year, the business earned $1.48 EPS. View Eli Lilly And Co's Earnings History.

Eli Lilly And Co is scheduled to release their next quarterly earnings announcement on Wednesday, October 23rd 2019. View Earnings Estimates for Eli Lilly And Co.

Eli Lilly And Co will be holding an earnings conference call on Wednesday, October 23rd at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link.

Eli Lilly And Co issued an update on its FY 2019 earnings guidance on Wednesday, October, 23rd. The company provided EPS guidance of $5.75-5.85 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.72. The company issued revenue guidance of $22-22.5 billion, compared to the consensus revenue estimate of $22.23 billion.

15 brokerages have issued 1-year price targets for Eli Lilly And Co's stock. Their predictions range from $106.00 to $143.00. On average, they anticipate Eli Lilly And Co's stock price to reach $127.60 in the next twelve months. This suggests a possible upside of 16.2% from the stock's current price. View Analyst Price Targets for Eli Lilly And Co.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eli Lilly And Co in the last year. There are currently 6 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Eli Lilly And Co.

Press coverage about LLY stock has been trending negative recently, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Eli Lilly And Co earned a news sentiment score of -2.5 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the immediate future. View News Stories for Eli Lilly And Co.

Eli Lilly And Co saw a decline in short interest in September. As of September 30th, there was short interest totalling 12,190,000 shares, a decline of 9.8% from the August 30th total of 13,510,000 shares. Based on an average daily volume of 3,610,000 shares, the days-to-cover ratio is currently 3.4 days. Currently, 1.4% of the company's stock are short sold. View Eli Lilly And Co's Current Options Chain.

Some companies that are related to Eli Lilly And Co include Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Pfizer (PFE), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Allergan (AGN), Mylan (MYL), Perrigo (PRGO), Jazz Pharmaceuticals (JAZZ), Horizon Therapeutics (HZNP), The Medicines (MDCO), Nektar Therapeutics (NKTR), Zogenix (ZGNX) and Pacira Biosciences (PCRX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Eli Lilly And Co investors own include Johnson & Johnson (JNJ), Pfizer (PFE), Merck & Co., Inc. (MRK), Intel (INTC), AT&T (T), Bank of America (BAC), Verizon Communications (VZ), General Electric (GE), Exxon Mobil (XOM) and JPMorgan Chase & Co. (JPM).

Eli Lilly And Co's stock is owned by a number of of retail and institutional investors. Top institutional investors include Lilly Endowment Inc. (12.08%), Robeco Institutional Asset Management B.V. (0.13%), OLD National Bancorp IN (0.07%), Strs Ohio (0.05%), Gateway Investment Advisers LLC (0.05%) and Assenagon Asset Management S.A. (0.04%). Company insiders that own Eli Lilly And Co stock include Aarti S Shah, Alfonso G Zulueta, Christi Shaw, Daniel Skovronsky, Donald A Zakrowski, Eli & Co Lilly, Enrique A Conterno, Jackson P Tai, Jeffrey N Simmons, Joshua L Smiley, Lilly Endowment Inc, Melissa S Barnes, Michael J Harrington, Myles O'neill, Stephen F Fry and Susan Mahony. View Institutional Ownership Trends for Eli Lilly And Co.

LLY stock was sold by a variety of institutional investors in the last quarter, including Atalanta Sosnoff Capital LLC, Lilly Endowment Inc., Ferguson Wellman Capital Management Inc., Gateway Investment Advisers LLC, Pennsylvania Trust Co, Varma Mutual Pension Insurance Co, Verde Servicos Internacionais S.A. and Calamos Advisors LLC. Company insiders that have sold Eli Lilly And Co company stock in the last year include Aarti S Shah, Alfonso G Zulueta, Christi Shaw, Donald A Zakrowski, Eli & Co Lilly, Enrique A Conterno, Lilly Endowment Inc, Melissa S Barnes, Michael J Harrington, Myles O'neill and Stephen F Fry. View Insider Buying and Selling for Eli Lilly And Co.

LLY stock was purchased by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Robeco Institutional Asset Management B.V., Fulton Breakefield Broenniman LLC, Candriam Luxembourg S.C.A., State of Alaska Department of Revenue, CWM LLC, Strs Ohio and Private Capital Advisors Inc.. Company insiders that have bought Eli Lilly And Co stock in the last two years include Daniel Skovronsky, Jackson P Tai and Joshua L Smiley. View Insider Buying and Selling for Eli Lilly And Co.

Shares of LLY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of LLY stock can currently be purchased for approximately $109.84.

Eli Lilly And Co has a market capitalization of $106.04 billion and generates $24.56 billion in revenue each year. The company earns $3.23 billion in net income (profit) each year or $5.55 on an earnings per share basis. Eli Lilly And Co employs 38,680 workers across the globe.View Additional Information About Eli Lilly And Co.

The official website for Eli Lilly And Co is http://www.lilly.com/.

Eli Lilly And Co's mailing address is LILLY CORPORATE CENTER, INDIANAPOLIS IN, 46285. The company can be reached via phone at 317-276-2000 or via email at [email protected]